Pemetrexed Disodium and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alex A. Adjei, MD, PhD
Roswell Park Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
248 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Providence Cancer Center
Anchorage, Alaska, United States
- Mayo Clinic Scottsdale
Scottsdale, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Eden Medical Center
Castro Valley, California, United States
- Saint Rose Hospital
Hayward, California, United States
- Alta Bates Summit Medical Center - Summit Campus
Oakland, California, United States
- Ccop - Bay Area Tumor Institute
Oakland, California, United States
- Highland General Hospital at St. George'S University School of Medicine
Oakland, California, United States
- Valley Care Medical Center
Pleasanton, California, United States
- Doctors Medical Center - San Pablo Campus
San Pablo, California, United States
- Mayo Clinic - Jacksonville
Jacksonville, Florida, United States
- Ccop - Atlanta Regional
Atlanta, Georgia, United States
- Northside Hospital Cancer Center
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Saint Joseph'S Hospital of Atlanta
Atlanta, Georgia, United States
- Wellstar Cobb Hospital
Austell, Georgia, United States
- Charles B. Eberhart Cancer Center at Dekalb Medical Center
Decatur, Georgia, United States
- Gwinnett Medical Center
Lawrenceville, Georgia, United States
- Kennestone Cancer Center at Wellstar Kennestone Hospital
Marietta, Georgia, United States
- Southern Regional Medical Center
Riverdale, Georgia, United States
- Curtis & Elizabeth Anderson Cancer Institute at Memorial Health University Medical Center
Savannah, Georgia, United States
- Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta, Georgia, United States
- Saint Anthony'S Hospital at Saint Anthony'S Health Center
Alton, Illinois, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- St. Joseph Medical Center
Bloomington, Illinois, United States
- Graham Hospital
Canton, Illinois, United States
- Memorial Hospital
Carthage, Illinois, United States
- Eureka Community Hospital
Eureka, Illinois, United States
- Galesburg Clinic
Galesburg, Illinois, United States
- Galesburg Cottage Hospital
Galesburg, Illinois, United States
- Mason District Hospital
Havana, Illinois, United States
- Hopedale Medical Complex
Hopedale, Illinois, United States
- Joliet Oncology-Hematology Associates, Limited - West
Joliet, Illinois, United States
- Mcdonough District Hospital
Macomb, Illinois, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center
Maywood, Illinois, United States
- Good Samaritan Regional Health Center
Mount Vernon, Illinois, United States
- Bromenn Regional Medical Center
Normal, Illinois, United States
- Community Cancer Center
Normal, Illinois, United States
- Community Hospital of Ottawa
Ottawa, Illinois, United States
- Oncology Hematology Associates of Central Illinois, Pc - Ottawa
Ottawa, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2006
- Primary completion
- 31 May 2007
- Completion
- 30 Apr 2010
- Last update posted
- 6 Jul 2016
- Registered enrollment
- 48
- Registry id
- NCT00268489
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.